Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05168605

Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions

The purpose of study is to evaluate whether home visit programs are an effective method for HTN and T2DM management as compared to standard of care clinic visits.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

UT Southwestern Medical Center

Dallas, Texas, 75390, United States

Location status: Recruiting

Location contact

Nora Gimpel, MD

CONTACT

[email protected]

About this study

The purpose of this study is to compare the health outcomes utilizing home medical visits to manage hypertension and type 2 diabetes as compared to standard of care clinic visits.

This project has 3 overall objectives:

  • To test the efficacy of home medical visits by Family Medicine physicians specifically designed for patients with hypertension (HTN) and Type 2 Diabetes Mellitus (T2DM)
  • To compare primary outcome of the patients randomly selected for home visits to similar patients receiving usual care in the clinical setting
  • To understand the efficacy and impact of the home visit from the patient perspective

Study participant will receive usual care from a resident doctor in home. There will be (2) home visits conducted over the course of this study that will include a comprehensive assessment of hypertension, type 2 diabetes, and social factors that may be impacting their health. Study participants will also be asked to complete several questionnaires related to their knowledge of chronic diseases, personal health management, and experience of the study home visits.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients ages 18-60
  • Spanish or English speaking
  • Diagnosis of HTN or BP >140/90 in last 3 months (based on medical record)
  • Hemoglobin A1C>8 in last 6 months (based on medical record)
  • Not pregnant

Exclusion criteria

  • Current oral steroid use
  • History of solid organ transplant
  • Language other than English or Spanish

Treatment and study plan

Home visit

Other

Patients receiving home Visits

Primary outcomes

  1. Change in Blood pressure

    Time frame: Baseline, 6 months

    Change in blood pressure will be measured at baseline, 6 months using an automated blood pressure machine. Blood pressure is measured as systolic blood pressure/diastolic blood pressure in millimeters of mercury

Study contacts

Contact information is provided by the study sponsor or research team.

Silvia Obregon, MSW

CONTACT

[email protected]

214-645-9532

Sponsors and collaborators

Lead sponsor

University of Texas Southwestern Medical Center

Other

Registry information

Important dates

Study start
2022
Primary completion
2026
Study completion
2026
First posted
Dec 23, 2021
Registry last updated
Feb 10, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.